Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Dilantin
Phenytoin sodium 30mg
Capsule
Pfizer New Zealand Limited
Pfizer Australia Pty Limited, Sydney, Australia
Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Dilantin
Phenytoin sodium 100mg
Capsule
Pfizer New Zealand Limited
Pfizer Australia Pty Limited, Sydney, Australia
Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Gazyva
Obinutuzumab 1000mg
Concentrate for infusion
Roche Products (NZ) Limited
Roche Diagnostics GmbH, Mannheim, Germany
|
Dated this 6th day of October 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz